Study: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of Deucravacitinib (BMS-986165) in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)
Seeking: Persons diagnosed with Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)
PI: Dr. Naveed Sami, MD
![](https://med.ucf.edu/media/2017/05/sami-bigimage.jpg)
![](http://med.ucf.edu/media/2024/01/sami-bigimage-edited.jpg)